Promotion of rapid testing for HIV in primary care (RHIVA2): A cluster-randomised controlled trial

The Lancet HIV

Volumn 2, Issue 6, 2015, Pages e229-e235

  Leber, W ^a   McMullen, H ^a   Marlin, N ^a   Bremner, S ^a   Boomla, K ^a   Kerry, S ^a   Martineau, A ^a   Griffi, C ^a   Ashcroft, R ^b   Anderson, J ^c,d   Millett, D ^c,d   Mguni, S ^c,d   Creighton, S ^c,d   Santos, A C ^e   Terris Prestholt, F ^e   Figueroa, J ^f   Hart, G ^g   Delpech, V ^h   Brown, A ^h   Rooney, G ^h   Sampson, M ⁱ   more..

^a Healthcare Iinnovation and Policy Unit   (United Kingdom)

^b Bartolome House   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f Department of Clinical Psychology   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h PUBLIC HEALTH ENGLAND   (United Kingdom)

ⁱ BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD ANALYSIS; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EDUCATION PROGRAM; FEMALE; GENERAL PRACTICE; HEALTH EDUCATION; HIV RAPID TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SEROLOGY; ADOLESCENT; BLOOD; EARLY DIAGNOSIS; HEALTH PROMOTION; HIV INFECTIONS; PRIMARY HEALTH CARE; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; EARLY DIAGNOSIS; FEMALE; HEALTH PROMOTION; HIV INFECTIONS; HUMANS; LONDON; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; YOUNG ADULT;

EID: 84931281319     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(15)00059-4     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas. HIV AIDS Surveill Rep 2013; 25.
2. Gebo KA, Fleishman JA, Conviser R, et al. Contemporary costs of HIV healthcare in the HAART era. AIDS 2010; 24: 2705-15.
3. Stover J, Korenromp EL, Blakley M, et al. Long-term costs and health impact of continued global fund support for antiretroviral therapy. PLoS One 2011; 6: e21048.
4. Public Health England. HIV in the United Kingdom: 2014 report. London: Public Health England, 2014.
5. Hamers FF, Phillips AN. Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med 2008; 9 (suppl 2): 6-12.
6. WHO Regional Offi ce for Europe. HIV/AIDS. Copenhagen: World Health Organisation, 2014.
7. British HIV Association. UK National Guidelines for HIV testing. London: British HIV Association, 2008.
8. National Institute for Health and Care Excellence. Increasing the uptake of HIV testing to reduce undiagnosed infection and prevent transmission among men who have sex with men. London: National Institute for Health and Care Excellence, 2011.
9. National Institute for Health and Care Excellence. Increasing the uptake of HIV testing to reduce undiagnosed infection and prevent transmission among black African communities living in England. London: National Institute for Health and Care Excellence, 2011.
10. Health Protection Agency. Time to Test for HIV: expanding HIV testing in healthcare and community services in England. London: Health Protection Agency, 2011.
11. Prost A, Griffi ths CJ, Anderson J, Wight D, Hart GJ. Feasibility and acceptability of off ering rapid HIV tests to patients registering with primary care in London (UK): a pilot study. Sex Transm Infect 2009; 85: 326-329.
12. Rayment M, Thornton A, Mandalia S, et al. HIV testing in non-traditional settings-the HINTS study: a multi-centre observational study of feasibility and acceptability. PLoS One 2012; 7: e39530.
13. Chou R, Selph S, Dana T, et al. Screening for HIV: systematic review to update the 2005 U.S. Preventive Services Task Force recommendation. Ann Intern Med 2012; 157: 706-18.
14. Paltiel AD, Weinstein MC, Kimmel AD, et al. Expanded screening for HIV in the United States-an analysis of cost-eff ectiveness. N Engl J Med 2005; 352: 586-95.
15. Yazdanpanah Y, Perelman J, DiLorenzo MA, et al. Routine HIV screening in Portugal: clinical impact and cost-eff ectiveness. PLoS One 2013; 8: e84173.
16. Evans S, Royston P, Day S. Minim: allocation by minimisation in clinical trials. 2013. http://www-users.york.ac.uk/~mb55/guide/ minim.htm (accessed Jan 6, 2010).
17. Department of Communities and Local Government. The English Indices of Deprivation 2008. London: UK Government, 2009.
18. Griffi ths C, Sturdy P, Brewin P, et al. Educational outreach to promote screening for tuberculosis in primary care: a cluster randomised controlled trial. Lancet 2007; 369: 1528-34.
19. O'Brien MA, Rogers S, Jamtvedt G, et al. Educational outreach visits: eff ects on professional practice and health care outcomes. Cochrane Database Syst Rev 2007; CD000409.
20. Forsetlund L, Bjorndal A, Rashidian A, et al. Continuing education meetings and workshops: eff ects on professional practice and health care outcomes. Cochrane Database Syst Rev 2009; CD003030.
21. Public Health England. Genitourinary medicine clinic activity dataset (GUMCADv2). 2013. https://www.gov.uk/genitourinarymedicine- clinic-activity-dataset-gumcadv2 (accessed April 30, 2013).
22. Eldridge SM, Ashby D, Kerry S. Sample size for cluster randomized trials: eff ect of coeffi cient of variation of cluster size and analysis method. Intl J Epidemiol 2006; 35: 1292-300.
23. Kahan BC, Morris TP. Improper analysis of trials randomised using stratifi ed blocks or minimisation. Stat Med 2012; 31: 328-40.
24. Peacock JL, Sauzet O, Ewings SM, Kerry SM. Dichotomising continuous data while retaining statistical power using a distributional approach. Stat Med 2012; 31: 3089-103.
25. Prost A, Elford J, Imrie J, Petticrew M, Hart GJ. Social, behavioural, and intervention research among people of Sub-Saharan African origin living with HIV in the UK and Europe: literature review and recommendations for intervention. AIDS Behav 2008; 12: 170-94.
26. Flodgren G, Eccles MP, Shepperd S, Scott A, Parmelli E, Beyer FR. An overview of reviews evaluating the eff ectiveness of fi nancial incentives in changing healthcare professional behaviours and patient outcomes. Cochrane Database Syst Rev 2011; CD009255.
27. Shojania KG, Jennings A, Mayhew A, Ramsay CR, Eccles MP, Grimshaw J. The eff ects of on-screen, point of care computer reminders on processes and outcomes of care. Cochrane Database Syst Rev 2009; CD001096.
28. Suthar AB, Ford N, Bachanas PJ, et al. Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches. PLoS Med 2013; 10: e1001496.
29. Anaya HD, Butler JN, Solomon JL, et al. Implementation of nurse-initiated rapid HIV testing at high-prevalence primary care sites within the U.S. Veterans Aff airs Health Care System. Sex Transm Dis 2013; 40: 341-45.
30. Sanders GD, Anaya HD, Asch S, et al. Cost-eff ectiveness of strategies to improve HIV testing and receipt of results: economic analysis of a randomized controlled trial. J Gen Intern Med 2010; 25: 556-63.